Corbus Pharmaceuticals Reports 2019 First Quarter Financial Results and Provides Clinical Updates

Go back to Corbus Pharmaceuticals Reports 2019 First Quarter Financial Results and Provides Clinical Updates

Corbus Pharma (CRBP) Misses Q1 EPS by 16c

May 9, 2019 7:19 AM EDT

Corbus Pharma (NASDAQ: CRBP) reported Q1 EPS of ($0.43), $0.16 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $1.53 million.

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

... More